retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports First Retatrutide phase 3 data,
Description
We anticipated the follow-up to be differential between the exposure groups but not likely to be associated with the outcome
Acute kidney injury (AKI), a common complication with an incidence between 2057% in patients with decompensated liver disease, is often a precursor to CKD. Early detection and optimal management are crucial since serum creatinine is a late indicator of kidney injury
Insulin drug pricing is a major concern in many countries, and Germany is no exception
She explained that this loss of muscle can lead to a lower metabolic rate, sunken skin and even osteoporosis in severe cases
